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In previous studies it was shown that transformation of AKR fibroblasts with 
3-methylcholanthrene was associated with a loss of surface fibronectin and that 
induction of differentiation of the transformed cells with N,N-dimethylformamide 
(DMF) was associated with reacquisition of surface fibronectin (Chakrabarty et al., 
J. Cell. Physiol. 133:415, 1987). It i s  shown in the present study that changes in 
surface fibronectin reflect altered fibronectin synthesis and altered fibronectin 
binding. Both the nontransformed cells (AKR-2B) and their transformed counter- 
parts (AKR-MCA) bound '"I-fibronectin in a receptor-like fashion, but the AKR- 
MCA cells had only 20% of the receptors found on the AKR-2B cells. Whole cell 
extracts prepared from the AKR-2B cells and separated by sodium dodecyl sufate- 
polyacrylamide gel electrophoresis under reducing conditions were examined for 
'251-fibronectin binding. Under these conditions, the majority of binding occurred 
to moieties with molecular weights of 180 kD, 150 kD, and 97 kD. Binding to 
similar moieties on the AKR-MCA cells was virtually absent but occurred rapidly 
after treatment with DMF. The appearance of these moieties paralleled the ac- 
quisition of '251-fibronectin binding activity by whole cells. Antibodies to the 
fibronectin receptor isolated from human placenta reacted with the DMF-sensi- 
tive moieties in immunoblot assays. Both the appearance of the fibronectin bind- 
ing moieties and the acquisition of '251-fibronectin binding activity by whole cells 
occurred within 6 hr of DMF treatment and increased over the subsequent 4 day 
period. The time course of these events paralleled closely the time course for 
induction of fibronectin biosynthesis by DMF. These changes in fibronectin bind- 
ing and fibronectin production were associated with alterations in cell-substrate 
adhesion. The AKR-26 cells rapidly attached and spread on bovine serum albu- 
min-coated dishes and on fibronectin-coated dishes, whereas the AKR-MCA cells 
were less adhesive on both substrates. Capacity to attach and spread was regained 
concomitantly with the induction of fibronectin binding and fibronectin produc- 
tion. Adhesion on both substrates was partially inhibited by antibodies to the 
fibronectin receptor and by RGDS. These studies suggest that fibronectin produc- 
tion and fibronectin binding are coregulated in AKR fibroblasts and that they 
function together to bring about changes in cell-substrate adhesion. 
Transformation of rodent cells with a variety of 
agents (physical, chemical, or viral) results in a dra- 
matic decrease in surface fibronectin (Hynes, 1976; Va- 
heri and Mosher, 1978; Hayman et al., 1981; Alitalo et 
al., 1982; Chakrabarty et al., 1987). It has recently 
been shown that transformation of rat fibroblasts with 
a single oncogene (Ha-Ras) has a similar effect 
(Chakrabarty et al., 1989b). Loss of surface fibronectin 
is not unique to rodent cells. In cells of many other 
species, including humans, malignant variants often 
have less fibronectin on their surface than their non- 
malignant counterparts (Vaheri and Ruoslahti, 1975; 
Yamada et al., 1978; Smith et al., 1981; Taylor- 
Papadimitriou et al., 1981; Varani et al., 1989). 
Whereas loss of surface fibronectin is a consistent fea- 
ture of transformation, agents that induce the expres- 
sion of normal phenotypic characteristics in trans- 
formed cells (i.e., differentiation agents) cause the 
reacquisition of surface fibronectin (Hayman et al., 
1980; Milhaud et al., 1980; Carlin et al., 1982; Sporn 
and Roberts, 1983; Tanaka and Nishida, 1985; Marks 
et al., 1985; Chakrabarty et al., 1987, 1988, 1989a; Va- 
rani et al., 1989). 
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What accounts for the alterations in surface fibro- 
nectin expression during transformation and differen- 
tiation is not fully understood. Alterations either in the 
production of fibronectin or in fibronectin binding 
could be responsible. Recent studies with human fibro- 
blasts (Ignotz and Massague, 1987; Roberts et al., 1988) 
and with murine 3T3 cells (Ryseck et al., 1989) suggest 
that fibronectin production and fibronectin receptor ex- 
pression may be coregulated. In the present study we 
have examined the relationship between fibronectin 
production and fibronectin binding in murine AKR-2B 
fibroblasts and their transformed counterparts, AKR- 
MCA cells. We show here that both fibronectin synthe- 
sis and fibronectin binding are reduced in the AKR- 
MCA cells relative to  the AKR-2B cells. It is further 
shown that treatment of the AKR-MCA cells with N,N- 
dimethylformamide (DMF), an agent previously shown 
to induce differentiation of AKR-MCA cells (Chakra- 
barty et al., 1984, 1985; Levine et al., 1985) and to 
induce the reexpression of surface fibronectin on these 
cells (Chakrabarty et al., 1987), leads to a rapid and 
concomitant induction of fibronectin synthesis and fi- 
bronectin binding. Alterations in fibronectin synthesis 
and fibronectin binding are directly correlated with al- 
terations in cell-substrate adhesion. Taken together, 
these data suggest that alterations in adhesive proper- 
ties that accompany transformation and differentiation 
of AKR mouse fibroblasts are the result of modulation 
of surface fibronectin, which in turn results from coor- 
dinated alterations in fibronectin synthesis and fibro- 
nectin receptor expression. 
MATERIALS AND METHODS 
Cells 
AKR mouse fibroblasts (AKR-2B) and their 3-meth- 
ylcholanthrene-transformed counterparts (AKR-MCA) 
were used in this study. Both cell lines were main- 
tained in monolayer culture using McCoy's 5A medium 
supplemented with 10% fetal bovine serum as culture 
medium. Growth was at 37°C and 5% COz. The cells 
were subcultured by trypsinization as required. The 
AKR-MCA cells were induced to differentiate by treat- 
ment with 1% (v/v) DMF in culture medium. The ef- 
fects of DMF on the biological properties of the AKR- 
2B and AKR-MCA cells have been described in 
previous reports (Chakrabarty et al., 1984,1985,1987; 
Levine et al., 1985). 
Reagents 
Human plasma fibronectin was obtained from 
GIBCO (Grand Island, NY), and rabbit polyclonal an- 
tifibronectin was obtained from Dako (Santa Barbara, 
CA). Rabbit polyclonal antibodies to the human fibro- 
nectin receptor were obtained from Telios (San Diego, 
CAI. The synthetic peptide from the cell-binding do- 
main of fibronectin (RGDS) and an inactive control 
peptide (GRADSP) were obtained from Telios. Analysis 
of the fibronectin by sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) under reducing 
conditions revealed a single band at M, 220-240 kD. It 
reacted with antifibronectin in enzyme-linked immu- 
nosorbent assay (ELISA) at antibody dilutions between 
1:l and 1:105 but did not react with rabbit polyclonal 
antibodies to laminin, thrombospondin, or type IV col- 
lagen. Each of these antibody preparations reacted 
with the appropriate antigen in ELISA. The antifi- 
bronectin, likewise, did not react with laminin, throm- 
bospondin, or type IV collagen at  any dilution between 
1:l and 1:106. The fibronectin stimulated attachment 
and spreading of a fibronectin-sensitive murine fibro- 
sarcoma cell line at concentrations as low as 0.5 pgi35 
mm (diameter) dish. 
Biosynthetic labeling 
Cells were plated in 100 mm (diameter) culture 
dishes at an approximate density of 5 x lo6 cells per 
dish. The cells were allowed to attach and spread for 1 
hr. They were then treated with 1% DMF (v/v). At var- 
ious times after DMF treatment, the cells were incu- 
bated for 1 hr in culture medium containing 100 pCi/ 
dish of 35S-methionine (1,000-1,400 pCi/pmole; NEN, 
Boston, MA). After the 1 hr incubation, the cells were 
lysed in a solution of phosphate-buffered saline (PBS) 
containing three detergents (1% Triton X-100,0.5% so- 
dium deoxycholate, and 0.1% SDS; all obtained from 
Sigma Chemical Co., St. Louis, MO) and protease in- 
hibitors, including 20 mM EDTA, 5 mM N-ethyl male- 
imide, 2 mM phenylmethylsulfonyl fluoride (PMSF), 
and 10 ~ 1 / 1 0  ml of a protease inhibitor cocktail con- 
taining: leupeptin, 1 mg/ml; antipain, 2 mg/ml; benza- 
midine, 10 mg/ml; aprotinin, 10,000 kallikrein-inacti- 
vating units/ml; chymostatin, 1 mg/ml; and pepstatin, 
1 mg/ml, as described by Ronnett et al. (1984) in stud- 
ies on the insulin receptor. All the protease inhibitors 
were obtained from Sigma Chemical Co. The cell ly- 
sates were frozen at -80°C, thawed, and clarified by 
ultracentrifugation (37,OOOg for 60 min). Immunoreac- 
tive fibronectin was precipitated with a 1 : l O O  dilution 
of the rabbit antifibronectin and protein A-Sepharose 
(Sigma Chemical Co.) according to the protocol of Rud- 
don et al. (1979). Normal rabbit serum served as a con- 
trol. The washed immunoprecipitates were eluted with 
boiling (5 min) in twofold concentrated Laemmli (1970) 
SDS-PAGE sample buffer containing 2% 2-mercepto- 
ethanol. The immunoprecipitated material was frac- 
tionated on a 5% polyacrylamide gel employing the 
Laemmli system. Radioactive bands were visualized by 
fluorography with En3Hance (NEN), exposing the 
dried gels to X-ray film (Kodak XAR-2) for 2 days. In 
addition, a small sample of each immunoprecipitate 
was counted in a p-scintillation counter to quantitate 
35S-methionine incorporation. The amount of radioac- 
tivity precipitated with antifibronectin was compared 
with the amount precipitated with 10% (final) trichlo- 
roacetic acid (TCA) to determine the percentage of total 
synthesized protein accounted for by fibronectin. 
Immunoblotting 
Whole cell extracts (nonradioactive) were fraction- 
ated by SDS-PAGE as described above and immuno- 
blotted with antifibronectin as previously described 
(Chakrabarty et al., 1987). Briefly, the proteins frac- 
tionated by SDS-PAGE were electrophoretically trans- 
ferred onto nitrocellulose sheets. The binding profiles 
of antibodies were assessed as follows. Following trans- 
fer, the nitrocellulose sheets were incubated in a block- 
ing solution containing 3% bovine serum albumin, 
0.05% Tween 20 in PBS, pH 7.2, a t  4°C overnight. The 
sheets were then washed once with 1% bovine serum 
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albumin Tween 20 in PBS and incubated with antibod- 
ies (1:1,000 dilution) in the same buffer on a gently 
rocking platform for 3-4 hr  a t  room temperature. The 
sheets were washed four times with 1% bovine serum 
albumin Tween 20 and incubated with the same buffer 
containing 500,000 cpm 1251-protein A (ICN, Irvine, 
CAI overnight on a gently rocking platform at room 
temperature. Following incubation, the sheets were 
washed several times in PBS containing 0.05% Tween 
20 and air dried. The binding of antibodies and lz5I- 
protein A to the antigens on the nitrocellulose sheets 
was visualized by autoradiography. As controls, other 
nitrocellulose sheets containing the transferred pro- 
teins were similarly treated with normal rabbit serum 
(1:1,000 dilution) or with '251-protein A in the absence 
of antibodies. No 1251-protein A binding was observed 
in the controls. Whole cell extracts were examined for 
binding of antibodies to the fibronectin receptor in the 
same manner. 
ELISAs 
ELISAs were used to quantitate the amount of im- 
munoreactive fibronectin secreted into the culture me- 
dium. For this, cells were plated a t  3 x lo5 cellddish in 
35 mm (diameter) cell culture dishes. Cells were al- 
lowed to attach and spread for l hr. Following this, the 
cells were washed two times in serum-free culture me- 
dium and incubated with serum-free McCoy's 5A me- 
dium supplemented with 200 pg/ml of bovine serum 
albumin. DMF (1% v/v) was added to one-half the 
wells. At various times later, 200 p1 of each culture 
fluid was added to wells of a 96-well plate (Falcon Plas- 
tics, Oxnard, CA) from lots that  had been prescreened 
for acceptability in ELISA reactions and incubated for 
4 hr  a t  37°C. Culture medium alone served as a control. 
Purified human plasma fibronectin (0.5-0.0005 pgl 
well) was also added to the assay plate in the same 
culture medium to serve as a standard. After the 4 hr  
incubation, the fluids were removed from the wells, 
and the assays were run exactly as described previ- 
ously (Varani et al., 1983). 
'251-fibronectin binding assay 
Fibronectin was iodinated with NalZ5I (Amersham, 
Arlington Heights, IL) using the chloramine T method 
to a specific activity of approximately 1 pCi/pg. Unre- 
acted NalZ5I was removed from the protein by gel fil- 
tration chromatography on Biogel P-10 (LKB, Uppsala, 
Sweden). Binding assays were performed as previously 
described, with some modifications (Riser et al., 1988; 
Chakrabarty et al., 1989b). Cells (3 x lo5) were seeded 
into 24-well culture dishes in McCoy's 5A medium con- 
taining 10% fetal bovine serum and incubated over- 
night at 37°C and 5% COP in a humidified incubator. 
The cells in monolayer were then washed twice with 
binding medium (serum-free McCoy's 5A medium con- 
taining 20 mM Hepes, pH 7.4, and 500 pg of bovine 
serum albumin/ml) and incubated for a n  additional 2 
h r  at 37°C and 5% CO, in binding medium. Following 
this, the binding medium was removed and appropriate 
amounts of 1251-labeled fibronectin in fresh binding me- 
dium in the presence or absence of 100-fold excess of 
unlabeled fibronectin was added. The cells were incu- 
bated at 37°C and 5% COz for 1 h r  and then washed 
four times in binding medium, with gentle shaking on 
a horizontal shaker. Following the last wash, the cells 
were detached from the culture dishes by trypsiniza- 
tion at  37"C, and the entire contents were transferred 
to test tubes for counting. The culture wells were 
rinsed once with the trypsin solution, which was then 
combined with corresponding test tubes for counting. 
All assays were performed in triplicate, with parallel 
cultures used to determine cell number. The amount of 
radioactivity specifically bound was determined by the 
following formula. 
cprn specifically bound 
= total cpm bound in the absence of unlabeled ligand 
~ cpm bound in the presence of 100-fold excess of unlabeled ligand 
Nonspecific fibronectin binding was found to be in the 
range of 20-25% of the total binding and was sub- 
tracted from total binding in each experiment. 
'251-fibronectin binding to cell lysates 
Cells were grown in 100 mm (diameter) dishes to an 
approximate density of 7.5 x lo6 cellddish. Cells ex- 
tracts were prepared as described previously (Chakra- 
barty et al., 1987) and separated by SDS-PAGE under 
reducing conditions. The proteins were electrophoreti- 
cally transferred onto nitrocellulose sheets. The bind- 
ing profile of 1251-fibronectin was assessed as follows. 
Following transfer, the nitrocellulose sheets were in- 
cubated in a blocking solution containing 3% bovine 
serum albumin, 0.05% Tween 20 in PBS, pH 7.2, at 4°C 
overnight. The sheets were then washed once with 1% 
bovine serum albumin Tween 20 in PBS and incubated 
with 1251-fibronectin (8 nM) with and without a 100- 
fold excess of unlabeled fibronectin in the same buffer 
on a gently rocking platform for 3-4 h r  a t  room tem- 
perature. The sheets were washed four times with 1% 
bovine serum albumin Tween 20. Following incuba- 
tion, the sheets were washed several times in PBS con- 
taining 0.05% Tween 20 and air dired. The binding of 
1251-fibronectin was visualized by autoradiography us- 
ing Kodak XAR-2 film. This procedure has been used 
previously by others to identify fibronectin-binding 
and laminin-binding moieties (Codogno et al., 1987; 
Kleinman et al., 1988). 
Adhesion assay 
Cells were examined for attachment and spreading 
on plastic culture dishes in the presence of bovine se- 
rum albumin. The cells were harvested from culture, 
washed twice in serum-free medium, and added to the 
wells of a 24-well cluster dish (3 x lo5 cells per well) in 
serum-free medium supplemented with 200 pg/ml of 
bovine serum albumin. The wells were incubated at 
37"C, and, at various times later, the nonattached cells 
were removed and counted. The wells were then 
flooded with 2% glutaraldehyde, and the percentage of 
spread cells was assessed microscopically. By combin- 
ing the two values, a percentage of the originally added 
cells that were attached and spread a t  each time point 
was obtained. In some experiments, wells were treated 
for 2 hr  with human plasma fibronectin prior to use. 
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Fig. 1. A Binding studies with '251-fibronectin. Binding assays were 
carried out as described in Materials and Methods. Values shown 
represent the averages based on triplicate sampleddata point in a 
single experiment in which standard deviations were within 10% of 
the averages. Nonspecific binding, which routinely accounted for 20- 
RESULTS 
Fibronectin-binding by AKR-2B and 
AKR-MCA-cells 
Our previous studies showed that the AKR-2B cells 
were much more adhesive to fibronectin than the AKR- 
MCA cells and that DMF induced adhesion to fibronec- 
tin in the AKR-MCA cells (Chakrabarty et al., 1987). It 
was of interest, therefore, to determine if differences in 
response to fibronectin were related to differential fi- 
bronectin binding capacity. To determine this, we used 
a 1251-fibronectin-binding assay to compare AKR-2B 
and AKR-MCA cells. With both cell lines, binding of 
1251-fibronectin occurred in a receptor-like fashion. 
That is, binding was concentration-dependent, satura- 
ble, and inhibitable with excess unlabeled fibronectin. 
Binding curves for both cell lines are shown in Figure 
1. It can be seen that the number of binding siteskell 
distinguished the two cell lines. We estimated that 
25% of the total binding, was determined in the presence of 100-fold 
excess unlabeled fibronectin and has been subtracted from each data 
point. The experiment was repeated three times with similar results. 
B-D Scatchard analysis of the binding data. 
there were 8.0 x lo4 binding siteslAKR-2B cell and 
2.0 x lo4  sites/AKR-MCA cell. In addition, the average 
affinity of binding was slightly greater to the AKR-2B 
than AKR-MCA cells (Kd 22 vs. 45 nM) (Fig. 1). Effects 
of DMF on 1251-fibronectin binding by the AKR-MCA 
cells was examined next. As can be seen in Figure 1, 
treatment of the AKR-MCA cells with 1% DMF for 4 
days stimulated fibronectin binding in these cells to a 
level comparable to that observed with the AKR-ZB 
cells. The same treatment had only minimal effect on 
fibronectin binding by the AKR-2B cells (not shown). 
To examine the time course of DMF-mediated 
changes in fibronectin binding, AKR-MCA cells were 
plated in wells of a 24-well dish and incubated for vary- 
ing periods of time with 1% DMF. 1251-fibronectin bind- 
ing studies were then carried out in the normal manner 
using a single concentration of fibronectin (8 nM). 
DMF treatment induced a detectable increase in fibro- 
nectin binding by the AKR-MCA cells as early as 6 hr 
TABLE 1. '251-fibronectin binding to AKR-PB and 
AKR-MCA fibroblasts' 
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cPM specifically Percent of 
DMF bound per AKR-2B 
Cells treatment lo6 cells control 
AKR-2B None 120,000 
AKR-MC A None 45,000 37.5 
AKR-MCA 2 Hours 50,000 41.6 
6 Hours 58,000 48.4 
24 Hours 64,000 53.3 
48 Hours 70,000 58.3 
72 Hours 82,000 68.3 
96 Hours 110,000 91.6 
'Binding assays were performed in 24 well tissue culture plates according to 
procedures described in Materials and Methods. The values represent the aver- 
age of three binding ex riments (with a standard error of less than 5%) using 
one saturating dose of EI-fibronectin (8 nM1 for each well. Nonspecific binding 
has been subtracted from the total amount of radioactivity bound. 
after treatment. The increase continued over the fol- 
lowing 3 days (Table 1). 
We next examined binding of 1251-fibronectin to 
whole cell extracts prepared from AKR-2B and AKR- 
MCA cells by detergent lysis. Control cells and cells 
treated with 1% DMF for varying periods of time were 
lysed and separated by electrophoresis on a 7.5% SDS- 
polyacrylamide gel under reducing conditions. The sep- 
arated proteins were then transferred to nitrocellulose 
as described in Materials and Methods and probed with 
1251-fibronectin. Figure 2 shows the pattern typically 
seen after autoradiography. Distinct binding moieties 
at Mr 180 kD, 150 kD, and 97 kD were visible in the 
extracts prepared from the AKR-2B cells (lane 6). 
Binding was specific in that 100-fold excess of unla- 
beled fibronectin completely inhibited binding (lane 7). 
In contrast to the results obtained with AKR-2B cells, 
there was almost no binding to extract proteins from 
the untreated AKR-MCA cells (lane 1). Binding was 
seen in these cells, however, after treatment with 
DMF. Bands could be seen as early as 6 hr  after treat- 
ment (not shown) and were clearly distinct by 1 day 
after treatment (lane 2). The bands increased in den- 
sity over the following 3 days (lanes 3-5) so that by day 
4 they were essentially as dark as the bands from the 
AKR-2B cells. A small but significant amount of bind- 
ing was also observed to moieties in the range of 50-60 
kD . 
The relationship between these fibronectin-binding 
moieties and the well-characterized integrin receptor 
for fibronectin is not known. To address this issue, we 
examined binding of rabbit polyclonal antibodies pre- 
pared against the human fibronectin receptor from pla- 
centa by whole cell extracts of the AKR-2B and AKR- 
MCA cells. Antibody binding and detection was done as 
described in Materials and Methods. As is shown in 
Figure 3, antibodies to the fibronectin receptor exhib- 
ited a broad band of reactivity in the 150-180 kD range 
with extract from the AKR-2B cells (lane 3). Antibody 
binding to this region of the gel was absent with ex- 
tract from control AKR-MCA cells (lane 1) but was 
seen in extract prepared from AKR-MCA cells one day 
after treatment with 1% DMF (lane 2). In addition to 
binding in this region of the gel, the antifibronectin 
antibody reacted with moieties in the 97 kD region of 
the gel and with lower molecular weight bands. Bind- 
ing to these moieties, however, did not distinguish ex- 
tracts from three populations. 
Fig. 2. '"'I-fibronectin binding to cell lysate proteins obtained from 
AKR-ZB and AKR-MCA cells. Cell lysate proteins were prepared and 
binding studies carried out as described in Materials and Methods. 
Forty micrograms of cell lzsate protein were used per lane, and each 
lanes was probed with '' I-fibronectin at a concentration of 8 nM. 
Lane 1: AKR-MCA lanes AKR-MCA treated with 1% DMF for 
1, 2, 3, and 4 days respectively; lane 6 AKR-2B; lane 7: AKR-2B in 
the presence of 100-fold excess nonlabeled fibronectin. 
Effects of DMF on fibronectin production by  
AKR-MCA cells 
In our previous studies (Chakrabarty et al., 1987) we 
showed that fibronectin production was lower in AKR- 
MCA cells than in AKR-2B cells and that i t  was stim- 
ulated in AKR-MCA cells by treatment with DMF for 
4 days. We have in the present study examined the 
time course of fibronectin production in DMF-treated 
AKR-MCA cells. Biosynthetic labeling/immunoprecip- 
itation was used in the first series of experiments. Ta- 
ble 2 shows the time course of DMF-induced changes in 
total incorporation of 35S-methionine into 10% TCA- 
precipitable material (a measure of protein synthesis). 
Cells treated for 2 or 4 hr  with DMF were not signifi- 
cantly different from control cells. Reduced incorpora- 
tion was observed by 5 hr  (approximately 20% reduc- 
tion vs. untreated AKR-MCA cells examined in the 
same manner) and continued through 24 hr. After 24 
hr, total incorporation of 35S-methionine into TCA-pre- 
cipitable material from cultures of DMF-treated cells 
was only 28% of the amount incorporated into TCA- 
precipitable material from control cultures. On a per 
cell basis, total incorporation into TCA-precipitable 
material was reduced by approximately 50% in the 
treated cells compared with control cells. 
Table 2 also shows the effect of DMF treatment on 
incorporation of 35S-methionine into antifibronectin- 
precipitable material. Increased fibronectin biosynthe- 
sis (as a function of total protein synthesis) was de- 
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Fig. 3. Immunoblotting of cell lysate proteins obtained from AKR- 
2B and AKR-MCA cells. Cell lysate proteins were separated by SDS- 
PAGE, transferred to nitrocellulose, and blotted with antifibronectin 
receptor and '2"1-protein A as described in Materials and Methods. 
Lane 1: AKR-MCA lane 2 AKR-MCA treated for 1 day with l%, 
DMF lane 3 AKR-2B. 
TABLE 2. Time course of DMF stimulation of total protein 
synthesis and fibronectin synthesis in AKR-MCA cells 
%methionine Fibronectin 
(cpm incorporatedI2 (% of total 
Groun' ( X  109 Drotein?' 
No treatment 
DMF 2 hours 
DMF 4 hours 
DMF 5 hours 
DMF 6 hours 
DMF 8 hours 















Fig. 4. Immunoblotting of cell lysate proteins obtained from AKR- 
2B and AKR-MCA cells. Cell lysate proteins were separated by SDS- 
PAGE, transferred to nitrocellulose, and blotted with antifibronectin 
and '251-protein A as described in Materials and Methods. Lane  1: 
AKR-2B; lane 2: AKR-MCA; lanes 36: AKR-MCA treated with 1% 
DMF for 2 days, 1 day or 6 hr, respectively. 
of nonfibronectin proteins. Examination of antifi- 
bronectin-precipitated material from the DMF-treated 
AKR-MCA cells by SDS- PAGE under reducing condi- 
tions and autoradiography revealed a closely spaced 
doublet with molecular weights of 220-240 kD. Iden- 
tical forms were seen in extracts of the AKR-2B and 
AKR-MCA cells (not shown). Thus there appeared to be 
no qualitative changes in the molecular forms of fibro- 
nectin produced in response to DMF. 
Immunoblotting was used as  a second means of vi- 
sualizing changes in fibronectin production. Whole cell 
extracts were separated by SDS-PAGE and immuno- 
blotted as described in Materials and Methods. Figure 
4 shows antifibronectin reactive moieties in whole cell 
extracts prepared from AKR-2B cells and AKR-MCA 
cells with and without DMF. Extracts prepared from 
the AKR-MCA cells (lane 2) contained significantly 
less antifibronectin reactive material than extracts 
from AKR-2B cells (lane 1). However, extracts ob- 'AKR-MCA cells (1 x lo7) were plated in 100 mm (diameter) dishes using 
M ~ C O Y ' S  5A medium supplemented with 10% fetal bovine serum as culture me- tained from AKR-MCA cells 6 h r  after treatment with 
dium. At various times later, the cultures were treated with 1% DMF (final DMF (lane 5 )  showed increased amounts offibronectin, 
concentration). At the end of the incubation period, the cells were incubated for 
1 hr with 100 pCi of "S-methionine. Cell Iysates were prepared and analyzed for By days 1 and 2 (lanes 3 and 41, there was no detectable 
total incorporation of 3sS-methionine into TCA-precipitable material and into difference between AKR-2B cells and DMF-treated 
antifibronectin-precipitable material. 
'Values represent average cpm incorporated into 100 pl of cell extract based on AKR-MCA 
duplicate sampleddata p i n t  in a single experiment in which the individual ELISAS were used as a third means of identifying 
values were within 17% of the mean values. The experiment was repeated two changes in fibronectin production following DMF treat- 
times, with similar results. 
'Values represent the percentage of the cpm incorporated into total protein that ment. Culture fluids obtained from cells 30 min or 
were incorporated into antifibronectin-precipitable material. 2 hr  after DMF treatment showed slightly increased 
amounts of fibronectin. Culture fluids obtained 6 hr  or  
more after treatment showed significantly increased 
amounts (Table 3).  
Effects of DMF on AKR-MCA cell adhesion 
We knew from our previous studies that  the AKR-2B 
cells rapidly attached and spread on bovine serum al- 
tected by 6 hr. The percentage increase in fibronectin 
production was much greater than the percentage de- 
crease in total protein synthesis a t  6, 8, and 24 hr, 
indicating that the increase reflected actual increases 
in fibronectin synthesis as well as decreased synthesis 
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(4 TABLE 3. Time course of DMF stimulation of fibronectin production in AKR-MCA cells' 
Grouo 
Nanograms of fibronectid 
1 x lo5 cells 
30 Min control 
30 Min DMF 
2 Hr control 
2 Hr DMF 
4 Hr control 
4 Hr DMF 
6 Hr control 
6 Hr DMF 
18 Hr control 
18 Hr DMF 
60 % 10 
75 % 5 
68 I 4 
78 5 10 
96 2 30 
150 fr 11 
70 I 4 
140 2 8 
150 I 8
510 5 20 
'Culture fluids were obtained from control and DMF-treated 
cells and analyzed for fibronectin production by ELISA. Values 
represent average nanograms of fibronectinil x lo5 cells 2 dif- 
ferences between individual values and averages based on du- 
plicate sampleddata point in a single experiment. The experi- 
ment was repeated three times with similar results. 
bumin-coated dishes, whereas the AKR-MCA cells at- 
tached and spread much more slowly (Chakrabarty et 
al., 1987). That the rapid adhesion response of the 
AKR-2B cells was due to  surface fibronectin was 
strongly suggested by the finding that antibody to fi- 
bronectin but not to laminin inhibited this response. 
We therefore sought to determine in the present study 
if changes in AKR-MCA cell adhesion would parallel 
changes in fibronectidfibronectin receptor expression 
following DMF treatment. Cells were grown in mono- 
layer culture and treated with 1% DMF for varying 
periods of time. At the end of the treatment period, the 
cells were harvested by trypsinization and assayed for 
attachment and spreading on bovine serum albumin- 
coated dishes as described in Materials and Methods. 
AKR-MCA cells pretreated with DMF for 3 hr (but not 
for 1 or 2 hr) showed increased adhesion over untreated 
AKR-MCA cells. Increased attachment and spreading 
was detected by 2 hr (total elapsed time of 5 hr since 
treatment) (Fig. 5A). The change in adhesion induced 
by DMF parallels, therefore, changes in fibronectin 
production and fibronectin receptor expression. 
AKR-MCA cells were also examined for alterations 
in adhesion to fibronectin following treatment with 
DMF. Alterations in adhesion to fibronectin paralleled 
alterations in adhesion to plastic culture dishes in the 
presence of bovine serum albumin (Fig. 5B). That is, 
cells treated for 3 hr with 1% DMF attached and spread 
on fibronectin (10 pg) coated dishes more rapidly than 
untreated AKR-MCA cells. 
In additional experiments, antibodies to the human 
fibronectin receptor and the synthetic peptide RGDS 
from the cell-binding domain of fibronectin were exam- 
ined for effects on AKR-MCA cell adhesion. AKR-MCA 
cells that had been incubated for one day with 1% DMF 
were treated with the antifibronectin antibody or with 
RGDS and added to untreated or fibronectin-treated 
wells of a plastic culture dish. Normal rabbit serum 
and the synthetic peptide GRADSP served as controls. 
Attachment and spreading were measured in the nor- 
mal way. Table 4 shows that both the antibody to the 
fibronectin receptor and the synthetic peptide RGDS 
partially inhibited AKR-MCA cell adhesion. Adhesion 
on untreated dishes and on fibronectin-coated dishes 
was inhibited equally by both reagents. The two con- 
trol reagents did not inhibit adhesion (Table 4). 
DMF 3 hours 
2::5 No Treatment 
3 4 
TIME (HOURS) 
DMF 24 hours 






0.0 1.0  2.0 3.0 4.0 5 . 0  
TIME (HOURS) 
Fig. 5. Effects of DMF on AKR-MCA cell attachment and spreading 
on plastic culture dishes in the presence of bovine serum albumin (A) 
or on dishes coated with 10 kg fibronectin (B). The assays were car- 
ried out as described in Materials and Methods. Values shown repre- 
sent averages based on duplicate sampleddata point in a single ex- 
periment. The individual values were within 10% of the mean values. 
The experiment was repeated three times, with similar results. 
DISCUSSION 
Transformation of cells is associated with a loss of 
surface fibronectin (Hynes, 1976; Vaheri and Mosher, 
1978; Hayman et al., 1981; Alitalo et al., 1982; Chakra- 
barty et al., 1987, 1989b). Reacquisition of the normal 
phenotype following treatment with chemical differen- 
tiation agents is associated with the reexpression of 
surface fibronectin (Hayman et al., 1980; Milhaud et 
al., 1980; Charkrabarty et al., 1987, 1988, 1989a; Va- 
rani et al., 1989). What underlies the alteration in fi- 
bronectin expression during transformation and differ- 
entiation is not fully understood. Reduced fibronectin 
biosynthesis is a t  least partially responsible (Olden 
and Yamada, 1977; Smith et al., 1981; Taylor-Papa- 
dimitriou et al., 1981; Oliver et al., 1983; Senger et al., 
1983; Tanaka and Nishida, 1985; Chakrabarty et al., 
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TABLE 4. Inhibition of DMF-treated AKR-MCA cell attachment 
and spreading on plastic culture dishes and 
fibronectin-coated dishes' 
Percent attached and soread 
Treatment PlasticlBSA Fibronectin 
None 44 f 10 72 f 5 
Antifibronectin receptor ( 1 : l O )  12 2 5 36 f 9 
Normal rabbit serum ( 1 : l O )  40 f 6 79 f 4 
RGDS (100 Fg) 16 ? 4 24 f 5 
RGDS (50 kg) 8 i 5  32 2 8 
GRADSP (100 kg) 54 i 7 81 2 9 
GRADSP (50 ua) 50 ? 5 63 a 
'AKR-MCA cells were treated with 1% DMF for 1 day and then examined for 
attachment and spreading on plastic culture dishes in the presence of bovine 
serum albumin (BSA) or dishes coated with 10 pg fibronectin. Antisera or syn- 
thetic peptides were added to the assay buffer immediately before addition of 
cells. The percentage of cells that were attached and spread was determined after 
1 hr as described in Materials and Methods. Values shown represent averages 2 
differences between individual values and averages abased on duplicate samples 
in a single experiment. The experiment was repeated three times with similar 
results. 
1987,1989b). However, a reduction in fibronectin syn- 
thesis has not been observed in all transformed cells 
(Vaheri and Ruoslahti, 1975). 
An alternative explanation to  account for the re- 
duced surface fibronectin expression in transformed 
cells is a reduction in capacity of the transformed cells 
to bind fibronectin. The fibronectin receptor has been 
identified on a number of different cell types as a mem- 
ber of the integrin family of adhesion receptors (Pytela 
et al., 1985; Pate1 and Lodish, 1986; Giancotti et al., 
1986a,b; Cadarelli and Pierschbacher, 1987; Codogno 
et al., 1987; Confarti et al., 1989; Kerjaschki et al., 
1989). Plantefaber and Hynes (1989) recently reported 
that the fibronectin receptor was decreased on several 
transformed rodent cells compared with their normal 
counterparts. They suggested that decreased fibronec- 
tin binding rather than decreased fibronectin produc- 
tion was probably the key factor underlying the re- 
duced level of surface fibronectin expression on 
transformed cells. They also argued that altered fibro- 
nectin binding (rather than reduced fibronectin pro- 
duction) was probably critical to the alterations in ad- 
hesion that accompany transformation. 
In the present study we have examined the relation- 
ship between fibronectin production and fibronectin 
binding in transformed AKR fibroblasts under control 
conditions and during induction of differentiation with 
DMF. DMF has been shown in previous studies to  re- 
verse the transformed phenotype in these cells (Chak- 
rabarty et al., 1984, 1985, 1987; Levine et al., 1985). 
The present data indicate that both fibronectin produc- 
tion and fibronectin binding are greatly reduced in 3- 
methylcholanthrene-transformed AKR cells compared 
with their nonmalignant counterpart (AKR-2B) cells 
and that both are stimulated rapidly in the trans- 
formed cells (within 5-6 hr) after treatment with 
DMF. We had originally hoped to utilize the time 
course data to determine the sequence of events that 
occurred following DMF treatment, i.e., to determine if 
changes in fibronectin production occurred prior to al- 
terations in fibronectin binding or whether changes in 
binding preceeded changes in fibronectin production. 
These data could prove useful in efforts to understand 
the relationship between fibronectin production and 
up-regulation of its receptor. However, the similarities 
in the time courses for stimulation of fibronectin pro- 
duction and fibronectin binding do not allow us to do 
this. They do allow us to suggest that the two events 
are closely linked in the AKR cells. A similar conclu- 
sion was reached by Ignotz and Massague (1987) and 
by Roberts et al. (1988) in their studies on human fi- 
broblasts treated with transforming growth factor-p 
(TGF-P) and by Ryseck et al. (1989) in their studies on 
serum-stimulated fibroblasts. 
The nature of the DMF-sensitive, fibronectin-bind- 
ing moieties associated with the AKR cells was not 
delineated in the present study. When cell extracts 
(separated by SDS-PAGE under reducing conditions) 
were examined for fibronectin binding on nitrocellu- 
lose, the majority of binding occurred to moieties with 
apparent molecular weights of 180, 150, and 97 kD. It 
is possible that these moieties represent subunits of the 
integrin receptor for fibronectin. Alternatively, since 
we used extracts prepared from whole cells, it is possi- 
ble that much of the binding occurred to proteins that 
are not present in the mature cell surface receptor. 
Whether these moieties are related to the mature cell 
surface receptor is not clear. Additional studies will be 
needed to  determine if this is the case. If it turns out 
that the moieties responsible for fibronectin binding in 
the whole cell extract are related to the integrin recep- 
tor for fibronectin, this will be of interest in light of 
previous observations showing that the integrin com- 
plex from chick fibroblasts does not bind fibronectin 
under denaturing conditions (Buck et al., 1986). 
These experiments do not definitively show that the 
fibronectin binding moieties present in the whole cell 
extracts are members of the integrin family. It is clear, 
however, from the studies with the antifibronectin re- 
ceptor that the AKR cell extracts contain a moiety that 
is immunologically cross reactive with the fibronectin 
receptor. This moiety was detected in the extracts from 
the normal cells, was virtually absent in the extract 
from the transformed cells, and reappeared rapidly af- 
ter DMF treatment of the transformed cells. The loss of 
this moiety after transformation and reappearance af- 
ter treatment with DMF correlated with changes in 
fibronectin binding in the whole cell binding assay and 
also correlated with changes in cell-substrate adhesion 
under the same conditions. This is consistent, there- 
fore, with the suggestion that the immunologically 
cross reactive moiety is responsible for fibronectin 
binding by the AKR cells and for the attendant biolog- 
ical activity. The finding that the same antibody, as 
well as RGDS, was able to inhibit the adhesion re- 
sponse is also supportive. 
In addition to examining the relationship between 
fibronectin production and fibronectin binding, we also 
sought to delineate the relationship between both fi- 
bronectin production and binding on the one hand and 
cell-substrate adhesion on the other. It is clear from our 
data that the alterations in fibronectin production and 
fibronectin binding that accompany transformation 
and differentiation are closely associated with altered 
cell-substrate adhesion in the AKR cells. The trans- 
formed cells were less adherent than their untrans- 
formed counterparts to fibronectin and increased adhe- 
sion to this substrate occurred in concert with the 
reexpression of fibronectin binding capacity following 
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DMF treatment. Interestingly, changes in adhesion to 
plastic culture dishes in the presence of bovine serum 
albumin paralleled changes in adhesion to fibronectin. 
This most likely reflects altered fibronectin synthesis 
as well as fibronectin receptor expression. Antibodies 
to the fibronectin receptor as well as the synthetic pep- 
tide RGDS were effective in inhibiting adhesion to the 
plastic culture dishes in the presence of bovine serum 
albumin. These data strongly support the idea that al- 
tered adhesion is a reflection of changes in both fibro- 
nectin synthesis and fibronectin binding. Based on 
these data and our previous data (Chakrabarty et al., 
1987, 1989b1, we believe that the initial adhesion of 
rodent fibroblasts in culture (at least under serum-free 
conditions) is mediated through endogenously synthe- 
sized fibronectin interacting with cell surface fibronec- 
tin receptors. Since these receptors are directly linked 
to cytoskeletal elements (Chen et al., 1985; Damski et 
al., 1985), the interaction of ligand and receptor could 
lead to cytoskeletal reorganization and modulation of 
cell morphology as well as to the initial attachment of 
the cells to the substratum. 
It should be noted that decreased fibronectin receptor 
expression on transformed rodent fibroblasts is not in- 
dicative of a general loss of integrins. Plantefaber and 
Hynes (1989) noted that several integrins capable of 
binding fibronectin were present on transformed ro- 
dent cells in spite of the loss of the specific fibronectin 
receptor. Likewise, Giancotti et al. (1986a,b) observed 
that Rows sarcoma virus (RSVI-transformed fibro- 
blasts as well as control cells stained with an antibody 
to the integrin complex. Qualitative rather than quan- 
titative differences in the staining patterns were seen. 
Furthermore, the fibronectin receptor itself is not de- 
creased on all cells during transformation. Saga, Chen, 
and Yamada (1988) found increased expression of fi- 
bronectin receptors on fibrocytic tumors induced in 
chickens by RSV. Similar or increased levels of antifi- 
bronectin immunostaining have also been noted on the 
surface of transformed human cells relative to their 
nontransformed counterparts (Akiyama et al., 1990). 
Thus decreased ability to utilize fibronectin or other 
matrix components is not a necessary consequence of 
transformation. 
Studies from several laboratories have shown that 
rodent cells express receptors for laminin (Malinoff and 
Wicha, 1983; Rao et al., 1983; Kramer et al., 1989; 
Chakrabarty et al., 1989b). These cells also synthesize 
laminin (Varani et al., 1983; Chakrabarty et al., 1987, 
1989b). Thus it is possible that interaction of laminin 
and its receptor are involved in mediating the adhesion 
of rodent fibroblasts to their substratum. However, our 
studies with the AKR fibroblasts (Chakrabarty et al., 
1987) suggest that adhesion mediated through laminin 
probably does not play an important role in the initial 
attachment of these cells to the substratum. Evidence 
for this includes the fact that antibodies to laminin do 
not interfere with attachment and spreading of the un- 
transformed cells on bovine serum albumin-coated 
dishes and the fact that the transformed cells express 
as much (or greater amounts of) surface laminin as the 
untransformed cells, yet are defective in their initial 
attachment and spreading. Furthermore, the untrans- 
formed AKR cells produce much less laminin than f i -  
bronectin. and it accumulates much more slawlv. Thiis 
it is unlikely that laminin plays a major role in the 
initial adhesion process when the cells concomitantly 
produce much larger amounts of fibronectin and ex- 
press surface receptors for fibronectin. Although prob- 
ably not involved in the initial adhesion response, 
laminin-laminin receptor interaction may promote ad- 
hesion a t  later time points. Although they are defective 
in their initial attachment, transformed AKR fibro- 
blasts (Chakrabarty et al., 1987) as well as other trans- 
formed rodent fibroblasts (Varani et al., 1983, 1985; 
Chakrabarty et al., 1989b) that express laminin on 
their surface are capable of attaching and spreading on 
plastic culture dishes a t  longer time periods. In con- 
trast, cells that are defective in both fibronectin and 
laminin are deficient in their initial rates of attach- 
ment and in attachment a t  later time points (Varani et 
al., 1983, 1985). Whether these in vitro observations 
have in vivo counterparts is not known. However, the 
existance of multiple mechanisms of adhesion could ex- 
plain how malignant cells might demonstrate the re- 
duced adhesiveness necessary to allow cells to separate 
from the primary tumor and yet have the capacity to 
adhere to endothelial cells or to subendothelial base- 
ment membranes at secondary sites during the process 
of metastasis. 
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